Intérêt de l'approche de population pour l'étude de la variabilité pharmacocinétique en pédiatrie

Archives de Pediatrie

Volumn 3, Issue SUPPL. 1, 1996, Pages

  Burtin, P ^a   Jacqz Aigrain, E ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MIDAZOLAM;

ARTICLE; CHILD; FRANCE; HUMAN; NEWBORN; NONLINEAR SYSTEM; NONPARAMETRIC TEST; PHARMACOKINETICS; POPULATION DYNAMICS; AGE; CONFERENCE PAPER; GENETIC VARIABILITY; MODEL; PHARMACODYNAMICS;

CHILD; FRANCE; HUMANS; INFANT, NEWBORN; MIDAZOLAM; NONLINEAR DYNAMICS; PHARMACOKINETICS; POPULATION DYNAMICS; STATISTICS, NONPARAMETRIC;

EID: 0030070845     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0929-693x(96)86054-4     Document Type: Article

References (10)

1. Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm 1977;5:445-479
2. Grasela TH, Sheiner LB, Rambeck B et al. Steady-state pharmacokinetics of phenytoin from routinely collected patient data. Clin Pharmacokinet 1983;8:355-64
3. Steimer JL, Vozeh S, Racine-Poon A, Holford N, O'Neill R. The population approach: Rationale, methods, applications in clinical pharmacology and drug development. In: PE Welling, LP Balant, eds. Pharmacokinetics of drugs. Handbook of experimental pharmacology. Heidelberg: Springer-Verlag, 1994
4. Sheiner LB, Beal SL. Bayesian individualisation of pharmacokinetics: simple implementation and comparison with non-Bayesian methods. J Pharmacokinet Sci 1982;71:1344-8
5. Mallet A. Intérêt de la pharmacocinétique de population pour l'aide à la posologie des médicaments. In : Informatique et Santé. Vol 2. Heidelberg : Springer-Verlag, 1989:125-41
6. Mallet A. A maximum likelihood estimation method for random coefficient regression models. Biometrika 1986;73:645-56
7. Mentré F, Mallet A. Handling covariates in population pharmacokinetics. Int J Biomed Computing 1994;36:25-33
8. Jacqz-Aigrain E, Daoud P, Burtin P, Maherzi S, Beaufils F. Pharmacokinetics of midazolam during continuous infusion in critically ill neonates. Eur J Clin Pharmacol 1992;42:329-32
9. Jacqz-Aigrain E, Wood C, Robieux I. Pharmacokinetics of midazolam in critically ill neonates. Eur J Clin Pharmacol 1990;39:191-2
10. Burtin P, Jacqz-Aigrain E, Girard P et al. Population pharmacokinetics of midazolam in neonates. Clin Pharmacol Ther 1994;56:615-25